BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21354598)

  • 21. [Evaluation of clinical results in patients undergoing laparoscopic nephroureterectomy].
    Hamada S; Ito K; Takahashi M; Isono M; Tasaki S; Yoshii H; Kuroda K; Satou A; Asakuma J; Seguchi K; Horiguchi A; Sumitomo M; Asano T
    Hinyokika Kiyo; 2013 Apr; 59(4):217-23. PubMed ID: 23635456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of perioperative systemic chemotherapy in upper tract urothelial carcinoma.
    Gin GE; Ruel NH; Kardos SV; Sfakianos JP; Uchio E; Lau CS; Yuh BE
    Urol Oncol; 2017 May; 35(5):192-200. PubMed ID: 28041996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012).
    Chappidi MR; Kates M; Johnson MH; Hahn NM; Bivalacqua TJ; Pierorazio PM
    Urol Oncol; 2016 Dec; 34(12):531.e15-531.e24. PubMed ID: 27476032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective study.
    Hamaya T; Hatakeyama S; Tanaka T; Kubota Y; Togashi K; Hosogoe S; Fujita N; Kusaka A; Tokui N; Okamoto T; Yamamoto H; Yoneyama T; Yoneyama T; Hashimoto Y; Ohyama C
    BJU Int; 2021 Oct; 128(4):468-476. PubMed ID: 33484231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.
    Hosogoe S; Hatakeyama S; Kusaka A; Hamano I; Iwamura H; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ohyama C
    Eur Urol Focus; 2018 Dec; 4(6):946-953. PubMed ID: 28753881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nephroureterectomy vs. segmental ureterectomy of clinically localized, high-grade, urothelial carcinoma of the ureter: Practice patterns and outcomes.
    Piraino JA; Snow ZA; Edwards DC; Hager S; McGreen BH; Diorio GJ
    Urol Oncol; 2020 Nov; 38(11):851.e1-851.e10. PubMed ID: 32859461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.
    Porten S; Siefker-Radtke AO; Xiao L; Margulis V; Kamat AM; Wood CG; Jonasch E; Dinney CP; Matin SF
    Cancer; 2014 Jun; 120(12):1794-9. PubMed ID: 24633966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
    Aboumohamed AA; Krane LS; Hemal AK
    J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of the bladder cuff removal by open excision versus transurethral resection of the ureteral orifice after laparoscopic radical nephroureterectomy in upper urinary tract--urothelial carcinoma].
    Tibi B; Quintens H; Carpentier X; Albano L; Durand M; Amiel J
    Prog Urol; 2014 Feb; 24(2):94-101. PubMed ID: 24485078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma.
    Silberstein JL; Power NE; Savage C; Tarin TV; Favaretto RL; Su D; Kaag MG; Herr HW; Dalbagni G
    J Urol; 2012 Feb; 187(2):429-34. PubMed ID: 22177163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy.
    Childs MA; Wood CG; Spiess PE; Debiane LG; Hernandez M; Matin SF; Millikan RE; Siefker-Radtkie A; Scott SM; Pisters LL
    Can J Urol; 2010 Jun; 17(3):5184-9. PubMed ID: 20566011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.
    Hellenthal NJ; Shariat SF; Margulis V; Karakiewicz PI; Roscigno M; Bolenz C; Remzi M; Weizer A; Zigeuner R; Bensalah K; Ng CK; Raman JD; Kikuchi E; Montorsi F; Oya M; Wood CG; Fernandez M; Evans CP; Koppie TM
    J Urol; 2009 Sep; 182(3):900-6. PubMed ID: 19616245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma.
    Abouassaly R; Alibhai SM; Shah N; Timilshina N; Fleshner N; Finelli A
    Urology; 2010 Oct; 76(4):895-901. PubMed ID: 20646743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.
    Matin SF; Sfakianos JP; Espiritu PN; Coleman JA; Spiess PE
    J Urol; 2015 Dec; 194(6):1567-74. PubMed ID: 26094807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary-like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin-based chemotherapy after radical nephroureterectomy than do sporadic tumours.
    Hollande C; Colin P; de La Motte Rouge T; Audenet F; Yates DR; Phé V; Ouzzane A; Droupy S; Ruffion A; de La Taille A; Guy L; Cussenot O; Rozet F; Xylinas E; Zerbib M; Spano JP; Khayat D; Bitker MO; Rouprêt M;
    BJU Int; 2014 Apr; 113(4):574-80. PubMed ID: 23937547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic nephroureterectomy for upper tract transitional cell carcinoma: a critical appraisal.
    McNeill A; Oakley N; Tolley DA; Gill IS
    BJU Int; 2004 Aug; 94(3):259-63. PubMed ID: 15291848
    [No Abstract]   [Full Text] [Related]  

  • 37. Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma.
    Hashimoto T; Ohno Y; Nakashima J; Gondo T; Nakagami Y; Namiki K; Horiguchi Y; Yoshioka K; Ohori M; Tachibana M
    Jpn J Clin Oncol; 2015 Nov; 45(11):1064-8. PubMed ID: 26355160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy increases survival and downstaging of upper tract urothelial cancer.
    Davaro F; May A; McFerrin C; Raza SJ; Siddiqui S; Hamilton Z
    Can J Urol; 2019 Oct; 26(5):9938-9944. PubMed ID: 31629443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardized and Simplified Retroperitoneal Lymph Node Dissection During Retroperitoneal Laparoscopic Radical Nephroureterectomy for Urothelial Carcinoma of the Upper Ureter or Renal Pelvis: En Bloc Resection Technique.
    Kanno T; Kobori G; Kubota M; Funada S; Haitani T; Okada T; Higashi Y; Moroi S; Yamada H
    Urology; 2018 Feb; 112():85-91. PubMed ID: 29158173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy.
    Ouzzane A; Colin P; Ghoneim TP; Zerbib M; De La Taille A; Audenet F; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M
    World J Urol; 2013 Feb; 31(1):189-97. PubMed ID: 23229227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.